Have you ever wondered about PROSE® treatment and how it might help you? PROSE (prosthetic replacement of the ocular surface ecosystem) is a treatment pioneered by BostonSight. For thousands of patients suffering from the most complex ocular surface diseases, including keratoconus, dry eye disease, ocular GVHD, and corneal transplant complications, PROSE is often the ideal, and sometimes only, treatment capable of restoring visual function and reducing eye pain and light sensitivity, and all without surgery. Join us on October 1 for a 1-hour informational webinar where BostonSight's Chief Medical Officer, Dr. Dan Brocks, and Clinic Director, Darlene Riordan, provide information about PROSE treatment and how to access it. You'll also hear from Kinney, at PROSE patient who has Sjögren's Syndrome. Join us Wednesday, October 1, 2025 8:00 - 9:00 pm EDT Register today - https://us02web.zoom.us/webinar/register/WN_4HMyUF6DRsuLKm2ymC6cHQ #PROSE #PatientSuccess #PatientExperience #BostonSight #PatientCare #ScleralLens #ScleralLenses #Optometry #Optometrist #DryEyeDisease #DryEye #DryEyeRelief #Keratoconus #EyeCare #Scleral #ContactLens #SpecialtyLenses (fb)

Please note that BostonSight, including lab and consultation, will be closed on Friday, July 4th 2025. (fb)